Close

Press Releases

Zimmer Biomet Announces Launch of the Comprehensiveยฎ Vault Reconstruction System – the First Commercially Available Patient-matched Glenoid Implantย 

Zimmer Biomet Holdings Inc , a global leader in musculoskeletal healthcare,announced the launch of the Comprehensiveยฎ Vault Reconstruction System (VRS),the first patient-matched glenoid implant cleared to specifically treat patients with a severely deficient rotator cuff and extensive bone loss...

Largest Ever PACK EXPO Exceeds Highest of Expectations

On the 60th Anniversary of its debut, PACK EXPO International and the co-located Pharma EXPO served as the worldโ€™s largest and most comprehensive processing and packaging show in 2016. Show owner and producer PMMI, The Association...

MedImmune completes out-licensing agreement with Allergan for MEDI2070

AstraZeneca announced the completion of the licensing agreement between MedImmune, its global biologics research and development arm, and Allergan plc, for the global rights to MEDI2070. MEDI2070 is an IL-23 monoclonal antibody currently in a Phase...

Largest Ever PACK EXPO Exceeds Highest of Expectations

On the 60th Anniversary of its debut, PACK EXPO International and the co-located Pharma EXPO served as the worldโ€™s largest and most comprehensive processing and packaging show in 2016.Show owner and producer PMMI, The Association for Packaging and Processing...

Allergan Announces Partnership with Amy Dixon, Elite Paratriathlete, to Improve Patient-Physician Conversations About Irritable Bowel Syndrome with Diarrhea (IBS-D)

Allergan plc announced a national partnership with Amy Dixon, world champion paratriathlete and irritable bowel syndrome with diarrhea (IBS-D) patient. Through this partnership, Dixon will serve as a spokesperson to share her story with fellow IBS-D...

Shire launches CUVITRUโ„ข [Immune Globulin Subcutaneous (Human), 20% Solution] in the U.S. for Primary Immunodeficiency

Shire plc announces the launch of CUVITRU , 20% Solution], the first and only Subcutaneous 20% treatment option without proline available in the U.S. to treat adult and pediatric patients (two years of age and older) with primary immunodeficiency...

Sanofi Receives CHMP Recommendation for Approval of SuliquaTM in the EU

Sanofi announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion for the marketing authorization of SuliquaTM, the once-daily titratable fixed-ratio combination of basal insulin glargine 100...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate ยป